Table 6.
Item | g55 | p-Value | g90 | p-Value | d160 | p-Value | Puberty | p-Value | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
CON | HFD | CON | HFD | CON | HFD | CON | HFD | |||||
MDA, nmol/mg | 6.98 ± 0.14 | 7.55 ± 0.47 | 0.315 | 7.47 ± 0.57 | 9.57 ± 0.48 | <0.05 | 6.98 ± 0.22 | 6.42 ± 0.07 | 0.078 | 6.57 ± 0.85 | 4.95 ± 0.25 | 0.143 |
T-SOD, U/mg | 55.50 ± 0.69 | 62.42 ± 4.11 | 0.173 | 67.72 ± 2.77 | 57.55 ± 1.08 | <0.01 | 33.06 ± 1.87 | 25.51 ± 1.34 | <0.05 | 30.58 ± 0.47 | 33.07 ± 1.46 | 0.18 |
CuZn-SOD, U/mg | 47.17 ± 3.41 | 58.16 ± 4.40 | 0.119 | 65.52 ± 3.95 | 53.91 ± 1.67 | <0.05 | 23.61 ± 4.60 | 27.61 ± 4.39 | 0.563 | 25.04 ± 0.59 | 15.22 ± 1.84 | 0.143 |
GR, U/g | 22.18 ± 1.70 | 20.29 ± 0.97 | 0.389 | 21.00 ± 0.45 | 19.27 ± 0.64 | 0.05 | 11.39 ± 1.15 | 13.84 ± 1.47 | 0.258 | 14.70 ± 0.72 | 15.85 ± 0.52 | 0.265 |
GPx, U | 50.45 ± 4.50 | 55.00 ± 1.73 | 0.400 | 115 ± 3.19 | 95 ± 2.32 | <0.01 | 127.91 ± 9.51 | 90.49 ± 2.03 | <0.05 | 100 ± 9.97 | 146 ± 15.27 | 0.066 |
T-AOC, U/mg | 11.72 ± 0.52 | 8.69 ± 0.76 | <0.05 | 9.44 ± 0.59 | 6.86 ± 0.20 | <0.05 | 5.29 ± 0.22 | 3.28 ± 0.29 | <0.05 | 6.89 ± 0.22 | 5.81 ± 0.20 | <0.05 |
g55, at Day 55 of gestation of the fetus; g90, at Day 90 of gestation of the fetus; d160, at Day 160 of offspring; puberty, upon the offspring reaching puberty. CON, normal dietary group and gilts were fed diets containing 7.27% crude fat during of gestation; HFD, high fat dietary group and gilts were fed diets containing 11.78% crude fat during of gestation. MDA, determine malondialdehyde; T-SOD, total superoxide dismutase; CuZn-SOD, cytoplasmic copper/zinc superoxide dismutase; GR, glutathione reductase; GPx, glutathione peroxidase; T-AOC, total antioxidative capability (n = 4 for each group, the fetus samples were from 4 gilts, and each gilt provided 2 fetuses; the calculated average values of the two fetal ovaries for each gilt were used in the statistical analysis).